UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________

FORM 10-Q

______________

(Mark One)

☒   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarter Ended September 27, 2015

OR

☐   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from       to

Commission File Number 0-27460

 

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation) 2000 Technology Parkway Newark, New York (Address of principal executive offices) 16-1387013 (I.R.S. Employer Identification No.) 14513 (Zip Code)

___________________

Registrant's telephone number, including area code: (315) 332-7100

_____________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data file required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒  No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer: Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☐   Smaller reporting company ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares outstanding of the registrant's common stock was 15,219,620, net of 3,838,807 treasury shares, as of October 28, 2015.

1

ULTRALIFE CORPORATION

INDEX

		Page
PART I    FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements
	Consolidated Balance Sheets as of September 27, 2015 and December 31, 2014 (unaudited)	3
	Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Nine Month Periods Ended September 27, 2015 and September 28, 2014 (unaudited)	4
	Consolidated Statements of Cash Flows for the Nine Month Periods Ended September 27, 2015 and September 28, 2014 (unaudited)	5
	Notes to Consolidated Financial Statements	6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	17
Item 4.	Controls and Procedures	27
PART II    OTHER INFORMATION
Item 1.	Legal Proceedings	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	29
Item 6.	Exhibits	29
	Signatures	30
	Index to Exhibits	30

 2

PART I. FINANCIAL INFORMATION

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Dollars in Thousands)
(unaudited)
ASSETS
	September 27,			December 31,
	2015			2014
Current assets:
Cash and cash equivalents	$	14,585		$	17,711
Restricted cash		143			155
Trade accounts receivable, net of allowance for doubtful accounts of $361 and $340, respectively		11,242			11,295
Inventories, net		23,352			26,086
Prepaid expenses and other current assets		1,943			1,313
Due from insurance company		177			184
Deferred income taxes		106			106
Total current assets		51,548			56,850
Property, equipment and improvements, net		9,191			9,812
Goodwill		16,327			16,407
Other intangible assets, net		4,155			4,338
Security deposits and other non-current assets		131			235
Total assets	$	81,352		$	87,642
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	6,766		$	6,996
Accrued compensation and related benefits		2,398			1,725
Accrued expenses and other current liabilities		2,170			2,421
Income taxes payable		164			69
Total current liabilities		11,498			11,211
Deferred income taxes		4,623			4,462
Other non-current liabilities		56			56
Total liabilities		16,177			15,729
Commitments and contingencies
Shareholders' equity:
Preferred stock – par value $.10 per share; authorized 1,000,000 shares; none issued		—			—
Common stock – par value $.10 per share; authorized 40,000,000 shares; issued – 18,992,380 shares at September 27, 2015 and 18,941,544 shares at December 31, 2014; outstanding – 15,153,573 shares at September 27, 2015 and 17,340,813 shares at December 31, 2014		1,899			1,894
Capital in excess of par value		176,402			175,940
Accumulated deficit		(94,553	)		(96,920	)
Accumulated other comprehensive loss		(750	)		(467	)
Treasury stock - at cost; 3,838,807 shares at September 27, 2015 and
1,600,731 shares at December 31, 2014		(17,686	)		(8,420	)
Total Ultralife equity		65,312			72,027
Noncontrolling interest		(137	)		(114	)
Total shareholders’ equity		65,175			71,913
Total liabilities and shareholders' equity	$	81,352		$	87,642
The accompanying notes are an integral part of these consolidated financial statements.

 3

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME (LOSS)
(In Thousands except per share amounts)
(unaudited)
	Three month periods ended						Nine month periods ended
	September 27,			September 28,			September 27,			September 28,
	2015			2014			2015			2014
Revenues	$	19,044		$	16,062		$	57,176		$	46,546
Cost of products sold		13,144			11,576			39,410			33,513
Gross profit		5,900			4,486			17,766			13,033
Operating expenses:
Research and development		1,224			1,014			3,917			4,010
Selling, general and administrative		3,503			3,527			11,037			11,498
Total operating expenses		4,727			4,541			14,954			15,508
Operating income (loss)		1,173			(55	)		2,812			(2,475	)
Other (expense) income:
Interest income		—			3			2			12
Interest and financing expense		(65	)		(56	)		(197	)		(153	)
Miscellaneous		70			(158	)		39			(128	)
Income (loss) from continuing operations before income taxes		1,178			(266	)		2,656			(2,744	)
Income tax provision		130			60			312			177
Net income (loss) from continuing operations		1,048			(326	)		2,344			(2,921	)
Loss from discontinued operations, net of tax		—			—			—			(61	)
Net income (loss)		1,048			(326	)		2,344			(2,982	)
Net (income) loss attributable to non-controlling interest		(1	)		3			23			13
Net income (loss) attributable to Ultralife		1,047			(323	)		2,367			(2,969	)
Other comprehensive income:
Foreign currency translation adjustments		(349	)		29			(283	)		164
Comprehensive income (loss) attributable to Ultralife	$	698		$	(294	)	$	2,084		$	(2,805	)
Net income (loss) per share attributable to Ultralife common shareholders – basic:
Continuing operations	$	.07		$	(.02	)	$	.14		$	(.17	)
Discontinued operations		—			—			—			(.00	)
Total	$	.07		$	(.02	)	$	.14		$	(.17	)
Net income per share attributable to Ultralife common shareholders – diluted:
Continuing operations	$	.07					$	.14
Discontinued operations		—						—
Total	$	.07					$	.14
Weighted average shares outstanding – basic		15,633			17,490			16,503			17,510
Potential common shares		107						47
Weighted average shares outstanding – diluted		15,740						16,550
The accompanying notes are an integral part of these consolidated financial statements.

 4

ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (In Thousands)
(unaudited)
	Nine month periods ended
	September 27,			September 28,
	2015			2014
OPERATING ACTIVITIES:
Net income (loss)	$	2,344		$	(2,982	)
Loss from discontinued operations, net of tax		—			61
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:
Depreciation and amortization of financing fees		1,848			2,227
Amortization of intangible assets		180			232
Stock-based compensation		439			721
Loss on long-lived asset disposals		36			—
Changes in deferred income taxes		165			165
Changes in operating assets and liabilities:
Accounts receivable		(29	)		3,755
Inventories		2,621			(2,460	)
Prepaid expenses and other assets		(631	)		(197	)
Accounts payable and other liabilities		455			(1,017	)
Net cash provided by operating activities		7,428			505
INVESTING ACTIVITIES:
Cash paid for property, equipment and improvements		(1,310	)		(968	)
Change in restricted cash		12			—
Net cash used in investing activities		(1,298	)		(968	)
FINANCING ACTIVITIES:
Cash paid to repurchase treasury stock		(9,266	)		(589	)
Return of security deposit		49			—
Proceeds from issuance of common stock		28			11
Net cash used in financing activities		(9,189	)		(578	)
Effect of exchange rate changes on cash and cash equivalents		(67	)		123
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(3,126	)		(918	)
Cash and cash equivalents, beginning of period		17,711			16,489
Cash and cash equivalents, end of period	$	14,585		$	15,571
NON-CASH ITEMS:
Construction in progress in accounts payable	$	—		$	903

The accompanying notes are an integral part of these consolidated financial statements.

 5

ULTRALIFE CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Dollar amounts in thousands – except share and per share amounts)

(unaudited)

1. BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements of Ultralife Corporation (the “Company”) and subsidiaries have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and with the instructions to Rule 8-03 of Regulation S-X. Accordingly, they do not include all of the information and footnotes for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals and adjustments) considered necessary for a fair presentation of the Condensed Consolidated Financial Statements have been included. Results for interim periods should not be considered indicative of results to be expected for a full year. Reference should be made to the Consolidated Financial Statements and related notes thereto contained in our Form 10-K for the year ended December 31, 2014.

The December 31, 2014 condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.

Certain items previously reported in specific financial statement captions have been reclassified to conform to the current presentation.

Our quarters end on the last Sunday of the third month in the quarter, as opposed to a calendar month-based cycle for each fiscal quarter. While the actual dates for the quarter-ends will change slightly each year, we believe that there are not any material differences when making quarterly comparisons.

2. SHARE REPURCHASE PROGRAM

On April 28, 2014, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”) which became effective on May 1, 2014, under which the Company was authorized to repurchase up to 1.8 million shares of its outstanding common stock over a period not to exceed twelve months. The Share Repurchase Program has been extended through April 30, 2016, and the maximum number of shares authorized to be repurchased under the program has been increased to 3.4 million shares.

Share repurchases under this program are made in accordance with SEC Rule 10b-18 using a variety of methods, which may include open market purchases, privately negotiated transactions and block trades, or any combination of such methods, in compliance with applicable insider trading and other securities laws and regulations. With the exception of repurchases made during stock trading black-out periods under a 10b5-1 Plan, the timing, manner, price and amount of any repurchases are determined at the Company’s discretion. The Share Repurchase Program may be suspended, terminated or modified by the Company at any time and for any reason.  The Share Repurchase Program does not obligate the Company to repurchase any specific number of shares.

During the three month period ended September 27, 2015, the Company repurchased 748,582 shares under this program for a total cost (excluding fees and commissions) of $3,357.

During the nine month period ended September 27, 2015, the Company repurchased 2,225,437 shares under this program for a total cost (excluding fees and commissions) of $9,162.

 6

From the inception of the Share Repurchase Program on May 1, 2014 through October 28, 2015, the Company has repurchased 2,442,191 shares for an aggregate cost (excluding fees and commissions) of $9,877. The total remaining balance of shares authorized for repurchase under the Share Repurchase Program is 957,809 shares as of October 28, 2015.

3. INVENTORIES

Inventories are stated at the lower of cost or market with cost determined under the first-in, first-out (FIFO) method. The composition of inventories was:

	September 27,		December 31,
	2015		2014
Raw materials	$	12,601	$	15,100
Work in process		1,874		1,489
Finished goods		8,877		9,497
Total	$	23,352	$	26,086

4. PROPERTY, EQUIPMENT AND IMPROVEMENTS

Major classes of property, equipment and improvements consisted of the following:

	September 27,			December 31,
	2015			2014
Land	$	123		$	123
Buildings and leasehold improvements		7,441			7,437
Machinery and equipment		49,357			48,054
Furniture and fixtures		1,976			1,811
Computer hardware and software		4,562			4,452
Construction in process		679			1,351
		64,138			63,228
Less-accumulated depreciation		(54,947	)		(53,416	)
Net property, equipment and improvements	$	9,191		$	9,812

Depreciation expense for property, equipment and improvements was as follows:

	Three-month periods ended				Nine-month periods ended
	September 27,		September 28,		September 27,		September 28,
	2015		2014		2015		2014
Depreciation expense	$	617	$	709	$	1,795	$	2,174

5. GOODWILL, INTANGIBLE ASSETS AND LONG TERM ASSETS

a. Goodwill

The following table summarizes the goodwill activity by segment for the nine-month periods ended September 27, 2015 and September 28, 2014:

 7

	Battery & Energy			Communi- cations
	Products			Systems		Total
Balance - December 31, 2013	$	4,926		$	11,493	$	16,419
Effect of foreign currency translation		(12	)		—		(12	)
Balance – September 28, 2014		4,914			11,493		16,407
Effect of foreign currency translation		—			—		—
Balance - December 31, 2014		4,914			11,493		16,407
Effect of foreign currency translation		(80	)		—		(80	)
Balance – September 27, 2015	$	4,834		$	11,493	$	16,327

b. Intangible Assets

The composition of intangible assets was:

	at September 27, 2015
			Accumulated
	Cost		amortization			Net
Trademarks	$	3,563	$	—		$	3,563
Patents and technology		4,491		(4,193	)		298
Customer relationships		3,991		(3,715	)		276
Distributor relationships		377		(359	)		18
Total intangible assets	$	12,422	$	(8,267	)	$	4,155
		at December 31, 2014
			Accumulated
		Cost	amortization			Net
Trademarks	$	3,567	$	—		$	3,567
Patents and technology		4,509		(4,114	)		395
Customer relationships		4,029		(3,679	)		350
Distributor relationships		391		(365	)		26
Total intangible assets	$	12,496	$	(8,158	)	$	4,338

Amortization expense for intangible assets was as follows:

	Three-month periods ended				Nine-month periods ended
	September 27,		September 28,		September 27,		September 28,
	2015		2014		2015		2014
Amortization included in:
Research and development	$	32	$	44	$	97	$	131
Selling, general and administrative		29		34		83		101
Total amortization expense	$	61	$	78	$	180	$	232

The change in the cost value of total intangible assets from December 31, 2014 to September 27, 2015 is a result of the effect of foreign currency translations.

 8

6. REVOLVING CREDIT AGREEMENT

We have financing through a Revolving Credit, Guaranty and Security Agreement, dated as of May 24, 2013 (the “Credit Agreement”), and related security agreements with PNC Bank, National Association (“PNC”), which provides a $20 million secured asset-based revolving credit facility that includes a $1 million letter of credit sub-facility (the “Credit Facility”). The Credit Agreement provides that the Credit Facility may be increased with PNC’s concurrence to an amount not to exceed $35 million, provided such increase must occur prior to the last six months of the term, which expires on May 24, 2017.

Our available borrowing limit under the Credit Facility is based on a borrowing base formula equal to a percentage of accounts receivable, inventory and eligible foreign in-transit inventory. Interest is payable quarterly and accrues on outstanding indebtedness under the Credit Agreement at either a LIBOR-based rate or an alternate base rate, as defined in the Credit Agreement. We pay a quarterly fee on the Credit Facility’s unused availability at 0.375% per annum.

As of September 27, 2015, we had approximately $9,666 of borrowing capacity in addition to our cash on hand of $14,585, and we had no outstanding borrowings or outstanding letters of credit under the Credit Facility at either September 27, 2015 or December 31, 2014.

7. SHAREHOLDERS’ EQUITY

We recorded non-cash stock compensation expense in each period as follows:

	Three-month periods ended				Nine-month periods ended
	September 27,		September 28,		September 27,		September 28,
	2015		2014		2015		2014
Stock options	$	112	$	142	$	368	$	430
Restricted stock grants:
Employee		23		4		71		4
President and CEO		—		34		—		117
Board of Directors compensation –
stock grant		—		57		—		170
Total	$	135	$	237	$	439	$	721

These are more fully discussed as follows:

a. Stock Options

We have stock options outstanding from various stock-based employee compensation plans for which we record compensation expense relating to share-based payment transactions in our financial statements. As of September 27, 2015, there was $414 of total unrecognized compensation expense related to outstanding stock options, which is expected to be recognized over a weighted average period of 1.1 years.

The following table summarizes stock option activity for the nine-month period ended September 27, 2015:

 9

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2015		2,056,122		$	6.66
Granted		311,250			3.83
Exercised		(8,502	)		3.37
Forfeited or expired		(68,166	)		12.21
Outstanding at September 27, 2015		2,290,704			6.12		3.61	$	1,985
Vested and expected to vest at September 27, 2015		2,151,104			6.27		3.47	$	1,763
Exercisable at September 27, 2015		1,387,971		$	5.10		2.69	$	1,184

Cash received from stock option exercises under our stock-based compensation plans for the three-month periods ended September 27, 2015 and September 28, 2014 was $19 and $0, respectively. Cash received from stock option exercises for the nine-month periods ended September 27, 2015 and September 28, 2014 was $28 and $11, respectively.

b. Restricted Stock Awards

At September 27, 2015, our President and Chief Executive Officer held 60,000 unearned, unvested restricted stock units. These units vested subsequent to September 27, 2015 upon the satisfaction of the condition of our common stock having closed at a price of $5.00 per share or greater for 15 trading days in a 30 trading day period.

In addition, 49,200 shares of restricted stock were awarded to certain of our employees in September, 2014. 16,400 shares of these awards vested in September 2015. There is $60 of unrecognized compensation expense related to these restricted shares at September 27, 2015.

8. INCOME TAXES

We use the asset and liability method in accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse.

For the three-month periods ended September 27, 2015 and September 28, 2014, we recorded $130 and $60, respectively, in income tax expense. For the nine-month periods ended September 27, 2015 and September 28, 2014, we recorded $312 and $177, respectively, in income tax expense. These are detailed as follows:

 10

	Three-month periods ended				Nine-month periods ended
	September 27,		September 28,		September 27,		September 28,
	2015		2014		2015		2014
Current income tax provision:
Foreign	$	44	$	—	$	87	$	—
Federal		26		—		48		—
State		5		5		12		12
Deferred income tax provision		55		55		165		165
Total	$	130	$	60	$	312	$	177

Deferred income tax provision is primarily due to the recognition of deferred tax liabilities generated from goodwill and certain intangible assets that cannot be predicted to reverse for book purposes during our loss carryforward periods. The remaining expense in 2015 was primarily due to the income reported for our China operations during the period and estimated U.S. federal alternative minimum taxes, while the remaining expense in 2014 was primarily due to state income taxes.

Our overall effective tax rate is the result of the combination of income and losses in each of our tax jurisdictions, which is particularly influenced by the fact that we have recorded a full reserve against our deferred tax assets pertaining to cumulative historical losses for our U.S. operations and our U.K. subsidiary, as management does not believe, at this time, that it is more likely than not that we will realize the benefit of these losses. Our tax rate for the nine-month period ended September 27, 2015 was 11.7%, which was different from the federal statutory rate due to the effect of the utilization of fully reserved net operating loss carryforwards (“NOL”) as well as the effect of differing foreign income tax rates, principally in China. Our tax rate for the nine-month period ended September 28, 2014 was (6.5%), which was different from the federal statutory rate due to the loss incurred and our full reserve against our NOLs, and the effect of differing foreign income tax rates, principally in China.

We have substantial NOLs available to offset taxable income in the United States. However, we remain subject to the alternative minimum tax in the United States. The alternative minimum tax limits the amount of NOL available to offset taxable income to 90% of the current year income. We recorded a provision of $26 and $48 for U.S. alternative minimum tax for the three and nine months ended September 27, 2015, respectively, and no alternative minimum tax in either the three or nine months ended September 28, 2014. The payment of the alternative minimum tax normally results in the establishment of a deferred tax asset; however, we have established a full valuation allowance for this related deferred tax asset.

As of September 27, 2015, we have foreign and domestic NOL and credit carryforwards totaling approximately $85,200 and $1,400 available to reduce future taxable income. Included in our NOL carryforwards are foreign loss carryforwards of approximately $12,400 that can be carried forward indefinitely. The domestic NOL carryforward of $72,800 expires from 2019 through 2035. The domestic NOL carryforward includes approximately $2,900 for which a benefit will be recorded in capital in excess of par value when realized.

Our unrecognized tax benefits related to uncertain tax positions at September 27, 2015 pertain to foreign tax jurisdictions. The following table summarizes the activity related to our unrecognized tax benefits:

 11

	Nine month periods ended
	September 27,			September 28,
	2015			2014
Balance – beginning of period	$	7,296		$	7,296
Increases related to current year tax positions		—			—
Increases related to prior year tax positions		—			—
Decreases related to prior year tax positions		—			—
Expiration of statute of limitations for assessment of taxes		—			—
Settlements of examinations		(7,296	)		—
Balance – end of period	$	—		$	7,296

The release of uncertain tax positions in 2015 relates to the conclusion of a federal tax examination, resulting in a $21.4 million increase in the amount of our reported domestic NOL carryforward.

We file income tax returns in various jurisdictions including U.S. federal, U.S. state and foreign jurisdictions. We are routinely subject to examination by taxing authorities in these various jurisdictions. Our U.S. tax matters for the years 2000 through 2014 remain subject to examination by the Internal Revenue Service (“IRS”) and by various state and local tax jurisdictions due to our NOL carryforwards. Our tax matters for the years 2007 through 2014 remain subject to examination by the respective foreign tax jurisdiction authorities.

9. EARNINGS PER SHARE

Basic earnings per share (“EPS”) is computed by dividing earnings attributable to the Company’s common shareholders by the weighted-average shares outstanding during the period. Diluted EPS includes the dilutive effect of securities, if any, and is calculated using the treasury stock method. For the three-month period ended September 27, 2015, 1,026,282 stock options and 34,200 restricted stock units were included in the calculation of Diluted EPS as such securities are dilutive. Inclusion of these securities resulted in 107,000 additional shares in the calculation of fully diluted earnings per share. For the nine-month period ended September 27, 2015, 431,532 stock options and 34,200 restricted stock units were included in the calculation of Diluted EPS as such securities are dilutive. Inclusion of these securities resulted in 47,000 additional shares in the calculation of fully diluted earnings per share. Due to our net losses in both the three-month and nine-month periods ended September 28, 2014, no dilutive securities were considered.

There were 1,264,422 and 2,020,588 outstanding stock options for the three-month periods ended September 27, 2015 and September 28, 2014, respectively, that were not included in EPS as the effect would be anti-dilutive. There were 1,859,172 and 2,020,588 outstanding stock options for the nine-month periods ended September 27, 2015 and September 28, 2014, respectively, that were not included in EPS as the effect would be anti-dilutive.

 12

10. COMMITMENTS AND CONTINGENCIES

a. Purchase Commitments

As of September 27, 2015, we have made commitments to purchase approximately $358 of production machinery and equipment.

b. Product Warranties

We estimate future costs associated with expected product failure rates, material usage and service costs in the development of our warranty obligations. Warranty reserves are based on historical experience of warranty claims and generally will be estimated as a percentage of sales over the warranty period. In the event the actual results of these items differ from the estimates, an adjustment to the warranty obligation would be recorded. Changes in our product warranty liability during the first nine months of 2015 and 2014 were as follows:

	Nine month periods ended
	September 27, 2015			September 28, 2014
Accrued warranty obligations – beginning	$	376		$	513
Accruals for warranties issued		16			77
Settlements made		(29	)		(90	)
Effect of foreign currency translation		(5	)		—
Accrued warranty obligations – ending	$	358		$	500

c. Contingencies and Legal Matters

We are subject to legal proceedings and claims that arise from time to time in the normal course of business. We believe that the final disposition of such matters, other than the matters described below, will not have a material adverse effect on our financial position, results of operations or cash flows.

Dreamliner Litigation

In July 2013, an unoccupied Boeing 787 Dreamliner aircraft operated by Ethiopian Airlines was damaged by a fire while parked at London Heathrow Airport. We participated in and provided technical assistance in support of an investigation of this incident conducted by U.K. and U.S. regulatory authorities as well as by the manufacturer of the aircraft, as we are one of many downstream suppliers to that manufacturer.  A final report was issued by the Air Accidents Investigative Branch - - UK Civil Aviation regulatory authority, with findings indicating that the fire was caused by circumstances related to the plane’s emergency locator transmitter (“ELT”) manufactured and installed by another company. 

On May 4, 2015, we were notified of a lawsuit in which we were named, along with other suppliers to the aircraft manufacturer, concerning that 2013 fire. The suit was filed by Ethiopian Airlines Enterprise in the Commercial Court, Queen’s Bench Division of the High Court of Justice, London. The suit seeks as damages USD 42 million plus other unspecified amounts, including those for loss of use and diminution in value of the aircraft. We maintain liability and products liability insurance through reputable providers, and in accordance with our corporate practices, immediately advised and referred this matter to our insurers. We are working with those insurers and their counsel to respond to and actively defend against this action.

 13

A component of the ELT is a battery pack which incorporates Ultralife’s industry-standard lithium manganese dioxide non-rechargeable D-cell. Ultralife has had this cell in production since 2001, with millions of units produced and this cell is widely-used for global defense and commercial applications. This battery product has gone through rigorous safety and qualification testing, including United Nations Transport of Dangerous Goods, Manual of Tests and Criteria, and is authorized for use in aerospace applications under Technical Standard Order C142.

At this time, we believe that there is not a reasonable possibility that this incident will result in a material financial exposure to the Company.

Arista Power Litigation

In September 2011, we initiated an action against Arista Power, Inc. (“Arista”) and our former employee, David Modeen (“Modeen”), in the State of New York Supreme Court, County of Wayne, in which we allege that Arista recruited all but one of the members of its executive team from us, subsequently changed and redirected its business to compete directly with us by using our confidential information, and during the summer of 2011, recruited Modeen to become an Arista employee. As more fully disclosed in our Annual Report on Form 10-K for the year ended December 31, 2014, we allege that both Arista and Modeen breached agreements with us, that Arista’s employment of Modeen will inevitably lead to the disclosure and use of our trade secrets by Arista.  We seek damages as determined at trial and preliminary and permanent injunctive relief.  The defendants answered the allegations set forth in the Complaint and asserted claims against us, which have since been dropped.  

We initiated the September 2011 Complaint against Arista Power to protect our shareholders, customersand employees from the unauthorized use and theft of our investments in intellectual property, trade secrets and confidential information by Arista and its employees.  Protecting our intellectual property and know-how, developed and obtained at great cost to us to form our competitive position in the marketplace and create value for our shareholders and stakeholders, is a fundamental responsibility of all our employees.

Discovery in this action is ongoing, and we plan to continue to pursue our complaint against Arista.  It is not possible to predict the outcome of this action, whether we will be granted the injunctive relief we seek, nor the monetary amount, if any, which we may be awarded should we prevail.

11. BUSINESS SEGMENT INFORMATION

We report our results in two operating segments: Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes: lithium 9-volt, cylindrical and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories, such as cables. The Communications Systems segment includes: power supplies, cable and connector assemblies, RF amplifiers, amplified speakers, equipment mounts, case equipment, integrated communication system kits and communications and electronics systems design. We believe that reporting performance at the gross profit level is the best indicator of segment performance. As such, we report segment performance at the gross profit level and operating expenses as Corporate charges.

The components of segment performance were as follows:

 14

Three-Month Period Ended September 27, 2015:

	Battery & Energy Products		Communi- cations systems		Discontinued operations		Corporate			Total
Revenues	$	16,390	$	2,654	$	—	$	—		$	19,044
Segment contribution		4,774		1,126		—		(4,727	)		1,173
Interest, financing
and miscellaneous
expense, net								5			5
Tax provision								(130	)		(130	)
Discontinued operations
Noncontrolling interest								(1	)		(1	)
Net income attributable
to Ultralife										$	1,047
Total assets	$	35,828	$	28,191	$	—	$	17,333		$	81,352

Three-Month Period Ended September 28, 2014:

	Battery & Energy Products		Communi- cations systems		Discontinued operations		Corporate			Total
Revenues	$	13,913	$	2,149	$	—	$	—		$	16,062
Segment contribution		3,812		674		—		(4,541	)		(55	)
Interest, financing
and miscellaneous
expense, net								(211	)		(211	)
Tax provision								(60	)		(60	)
Noncontrolling interest								3			3
Net loss attributable
to Ultralife										$	(323	)
Total assets	$	39,568	$	29,649	$	—	$	18,323		$	87,540

Nine-Month Period Ended September 27, 2015:

	Battery & Energy Products		Communi- cations systems		Discontinued operations		Corporate			Total
Revenues	$	48,638	$	8,538	$	—	$	—		$	57,176
Segment contribution		14,100		3,666		—		(14,954	)		2,812
Interest, financing
and miscellaneous
expense, net								(156	)		(156	)
Tax provision								(312	)		(312	)
Noncontrolling interest								23			23
Net income attributable
to Ultralife										$	2,367

 15

Nine-Month Period Ended September 28, 2014:

	Battery & Energy Products		Communi- cations systems		Discontinued operations			Corporate			Total
Revenues	$	40,000	$	6,546	$	—		$	—		$	46,546
Segment contribution		10,489		2,544		—			(15,508	)		(2,475	)
Interest, financing
and miscellaneous
expense, net									(269	)		(269	)
Tax provision									(177	)		(177	)
Discontinued operations						(61	)					(61	)
Noncontrolling interest									13			13
Net loss attributable
to Ultralife											$	(2,969	)

12. FAIR VALUE OF FINANCIAL INSTRUMENTS

FASB’s guidance for the disclosure regarding fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure regarding fair value of financial instruments approximated their carrying values at September 27, 2015 and December 31, 2014. The fair value of cash, trade accounts receivable, trade accounts payable and accrued liabilities approximates carrying value due to the short-term nature of these instruments.

13. FIRE AT MANUFACTURING FACILITY

In June 2011, we experienced a fire that damaged certain inventory and machinery and equipment at our facility in China. The total amount of the loss pertaining to assets and the related expenses was approximately $1,589. We have pursued a claim against our insurance policy, with the majority of our insurance claim related to the recovery of damaged inventory. We have received payments in June 2012 and April 2013 totaling approximately $1,286 as a partial payment on our insurance claim, which resulted in no gain or loss being recognized. As of September 27, 2015, we reflect a receivable from the insurance company relating to this claim of $177, which is net of our deductible of approximately $130, and represents additional proceeds expected to be received.

14. RECENT ACCOUNTING PRONOUNCEMENTS AND DEVELOPMENTS

In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, “Revenue from Contracts with Customers.”  This ASU amends the existing accounting standards for revenue recognition and is based on the principle that revenue should be recognized to depict the transfer of goods or services to a customer at an amount that reflects the consideration a company expects to receive in exchange for those goods or services.  In April 2015, the FASB proposed a one year delay in the effective date of ASU 2014-09. This standard currently becomes effective for the Company on January 1, 2017, and the one-year delay, if promulgated as proposed, will make this standard effective for the Company on January 1, 2018. The Company is currently evaluating the potential impact of this new guidance as well as the available transition methods.

 16

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. This report contains certain forward-looking statements and information that are based on the beliefs of management as well as assumptions made by and information currently available to management. The statements contained in this report relating to matters that are not historical facts are forward-looking statements that involve risks and uncertainties, including, but not limited to, our reliance on a certain key customer; possible reduced or further delayed U.S. and foreign defense spending, including the uncertainty of government budget approvals; possible delays or lack of success in our efforts to develop new commercial applications for our products; possible declines in demand for products using our batteries or communications systems; general domestic and global economic conditions; variability in our quarterly and annual results and price of our common stock; the unique risks associated with our Chinese operations; the possibility of impairment of our intangible assets; potential breaches in security and other disruptions; the possibility that our resources could be overwhelmed by our growth prospects; residual effects of negative news related to our industries; potential significant costs from our warranties; loss of top management; possible disruptions in our supply of raw materials and components; failure of customers to meet the volume expectations in our supply agreements; our inability to adequately protect our proprietary and intellectual property; the possibility that our ability to use our NOL carryforwards in the future may be limited; possible adverse effects from violations of the U.S. Foreign Corrupt Practices Act and other anti-corruption laws; variability of foreign currencies; the process of U.S. defense procurement; possible effects of audits of our contracts by the U.S. and foreign governments; our compliance with the regulations for the shipment of our products; business disruptions and other safety risks including those caused by fires; government and environmental regulations; and other risks and uncertainties, certain of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those forward-looking statements described herein. When used in this report, the words “anticipate”, “believe”, “estimate” or “expect” or words of similar import are intended to identify forward-looking statements. For further discussion of certain of the matters described above and other risks and uncertainties, see Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2014.

Undue reliance should not be placed on our forward-looking statements. Except as required by law, we disclaim any obligation to update any risk factors or to publicly announce any changes in any of the beliefs, assumptions or information underlying or affecting any of the forward-looking statements contained in this Quarterly Report on Form 10-Q or our Annual Report on Form 10-K for the year ended December 31, 2014 to reflect new information or risks, future events or other developments.

The following discussion and analysis should be read in conjunction with the accompanying Condensed Consolidated Financial Statements and Notes thereto appearing elsewhere in this Form 10-Q and the Risk Factors and our Consolidated Financial Statements and Notes thereto contained in our Form 10-K for the year ended December 31, 2014.

The financial information in this Management’s Discussion and Analysis of Financial Condition and Results of Operations is presented in thousands of dollars, except for share and per share amounts. All figures presented below represent results from continuing operations, unless otherwise specified.

 17

General

We offer products and services ranging from power solutions to communications and electronics systems. Through our engineering and collaborative approach to problem solving, we serve government, defense and commercial customers across the globe. We design, manufacture, install and maintain power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories and custom engineered systems. We continually evaluate ways to grow and broaden the scope of our products and services, including the design, development and sale of new products, expansion of our sales force to penetrate new markets and geographies, as well as seeking opportunities to expand through acquisitions. We sell our products worldwide through a variety of trade channels, including original equipment manufacturers (“OEMs”), industrial and defense supply distributors and directly to U.S. and international defense departments.

We report our results in two operating segments: Battery & Energy Products and Communications Systems. The Battery & Energy Products segment includes lithium 9-volt, cylindrical and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems and accessories, such as cables. The Communications Systems segment includes RF amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems kits and communications and electronics systems design. We believe that reporting performance at the gross profit level is the best indicator of segment performance.  As such, we report segment performance at the gross profit level and operating expenses as corporate charges. (See Note 12 in the Notes to Consolidated Financial Statements)

Overview

Consolidated revenues of $19,044 for the three-month period ended September 27, 2015 increased by $2,982 or 18.6%, from $16,062 during the three-month period ended September 28, 2014, due primarily to increased orders from U.S. government and defense customers for our Battery & Energy Products and Communications Systems businesses.

Gross profit for the three-month period ended September 27, 2015 was $5,900, or 31.0% of revenues, compared to $4,486, or 27.9% of revenues, for the same quarter a year ago. The 310 basis points improvement is due primarily to favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements.

Operating expenses increased to $4,725 during the three-month period ended September 27, 2015, compared to $4,541 during the three-month period ended September 28, 2014, resulting primarily from commissions related to the increased revenues and higher new product development costs.

The increased revenue and resulting leverage on gross profit along with lower operating expenses resulted in an operating profit of $1,173 for the three-month period ended September 27, 2015, compared to an operating loss of $55 for the three-month period ended September 28, 2014. The year-over-year improvement in operating profit of $1,228 resulted from the 18.6% increase in sales that contributed $832 to the improvement of operating profit and the 310 basis point improvement in gross margin which contributed $583, partially offset by the higher operating expenses which reduced operating profit by $184.

Net income was $1,048, or $0.07 per diluted share, for the three-month period ended September 27, 2015, compared to a net loss of $(326), or $(0.02) per basic share, for the three-month period ended September 28, 2014.

 18

Adjusted EBITDA from continuing operations, defined as net income (loss) attributable to Ultralife before net interest expense, provision (benefit) for income taxes, depreciation and amortization, amounted to $2,055 in the third quarter of 2015 compared to $815 in the third quarter of 2014. See the section “Adjusted EBITDA from continuing operations” beginning on Page 23 for a reconciliation of Adjusted EBITDA from continuing operations to net income (loss) attributable to Ultralife.

As a result of careful working capital management and cash generated from operations, our liquidity remains solid with no debt, and cash and cash equivalents of $14,585, a $3,126 or 17.7% decrease from our cash position of $17,711 at December 31, 2014. The decrease in cash and cash equivalents from year-end 2014 is primarily attributable to our purchases of stock under our Share Repurchase Program which totaled $9,228 inclusive of fees and commissions related to such purchases, partially offset by cash generated from our operating results and a 10.5% inventory reduction.

With our new products gaining traction and our opportunity set widening, we firmly believe our plans to produce revenue and earnings growth for 2015 are within reach.

Results of Operations

Three-month periods ended September 27, 2015 and September 28, 2014

Revenues. Consolidated revenues for the three-month period ended September 27, 2015 amounted to $19,044, an increase of $2,982, or 18.6%, from the $16,062 reported for the three-month period ended September 28, 2014.

Battery & Energy Products revenues increased $2,477, or 17.8%, from $13,913 for the three-month period ended September 28, 2014 to $16,390 for the three-month period ended September 27, 2015. The increase was primarily attributable to higher shipments of batteries to U.S. government and defense customers, which helped to increase government and defense shipments by 31.3% over the 2014 period, and now comprise 44% of total Battery & Energy Products sales versus 39% for the third quarter of 2014. Commercial revenues for the third quarter of 2015 increased 9.1% over the year-earlier period due to higher shipments of 9-Volt batteries to large global smoke detector OEM’s and rechargeable batteries and chargers into medical channels.

Communications Systems revenues increased $505, or 23.5%, from $2,149 in the three-month period ended September 28, 2014 to $2,654 for the three-month period ended September 27, 2015. Similar to the first two quarters of 2015, for the third quarter, we continued to experience more broad-based sales as well as increases in our order flow reflecting increased demand from system integrators in support of U.S. Department of Defense program and international projects.

Cost of Products Sold. Cost of products sold totaled $13,144 for the quarter ended September 27, 2015, an increase of $1,568, or 13.5%, from the $11,576 reported for the same quarter a year ago. Consolidated cost of products sold as a percentage of total revenue decreased from 72.1% for the three-month period ended September 28, 2014 to 69.0% for the three-month period ended September 27, 2015. Correspondingly, consolidated gross margin was 31.0% for the three-month period ended September 27, 2015, compared with 27.9% for the three-month period ended September 28, 2014, reflecting favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements.

 19

In our Battery & Energy Products segment, the cost of products sold increased $1,515, from $10,101 during the three-month period ended September 28, 2014 to $11,616 during the three-month period ended September 27, 2015. Battery & Energy Products’ gross profit for the third quarter of 2015 was $4,774, or 29.1% of revenues, an increase of $962 from gross profit of $3,812, or 27.4% of revenues, for the third quarter of 2014. Battery & Energy Products’ gross margin as a percentage of revenues increased for the three-month period ended September 27, 2015 by 170 basis points, reflecting favorable product mix, higher production volume and ongoing productivity improvements through the Lean process.

In our Communications Systems segment, the cost of products sold increased $53 or 3.6% from $1,475 during the three-month period ended September 28, 2014 to $1,528 during the three-month period ended September 27, 2015. Communications Systems’ gross profit for the third quarter of 2015 was $1,126, or 42.4% of revenues, an increase of $452 from gross profit of $674, or 31.4% of revenues, for the third quarter of 2014. The 1,100 basis points increase in gross margin as a percentage of revenue during 2015 is driven primarily by both product mix and production volume.

Operating Expenses. Operating expenses for the three-month period ended September 27, 2015 totaled $4,725, an increase of $184 or 4.1% from the $4,541 recorded during the three-month period ended September 28, 2014, resulting primarily from continued tight control over all discretionary spending.

Overall, operating expenses as a percentage of revenues were 24.8% for the quarter ended September 27, 2015 compared to 28.3% for the quarter ended September 28, 2014. Amortization expense associated with intangible assets related to our acquisitions was $61 for the third quarter of 2015 ($29 in selling, general and administrative expenses and $32 in research and development costs), compared with $78 for the third quarter of 2014 ($34 in selling, general, and administrative expenses and $44 in research and development costs). Research and development costs were $1,224 for the three-month period ended September 27, 2015, an increase of $210, or 20.7%, from $1,014 for the three-months ended September 28, 2014, as we continued to focus our spending on the development of new products with the highest estimated return on investment. Selling, general, and administrative expenses decreased $24, or 0.7%, to $3,503 during the third quarter of 2015 from $3,527 during the third quarter of 2014, reflecting continued actions to reduce discretionary expenses.

Other Income (Expense). Other income (expense) totaled $5 for the three-month period ended September 27, 2015 compared to ($211) for the three-month period ended September 28, 2014. Interest and financing expense, net of interest income, increased $12, to $65 for the third quarter of 2015 from $53 for the comparable period in 2014, as a result of costs to insure certain non-U.S. accounts receivable consistent with our Credit Agreement with PNC Bank. Miscellaneous income (expense) amounted to $70 for the third quarter of 2015 compared with ($158) for the third quarter of 2014, primarily due to transactions impacted by changes in foreign currencies.

Income Taxes. We reflected a tax provision of $130 for the third quarter of 2015, an increase of $70 as compared to the $60 provision reported for the third quarter of 2014, primarily as a result of estimated U.S. federal alternative minimum taxes and foreign income taxes.

See Note 8 in the Notes to Condensed Consolidated Financial Statements for additional information regarding our income taxes.

 20

Certain of our NOL carryforwards are subject to U.S. alternative minimum tax such that carryforwards can offset only 90% of alternative minimum taxable income. This limitation resulted in an estimated alternative minimum income tax provision for the third quarter of 2015 but did not have an impact on income taxes determined for the third quarter of 2014. The use of our U.K. NOL carryforwards may be limited due to the change in the U.K. operation during 2008 from a manufacturing and assembly center to primarily a distribution and service center and its subsequent change to a sales center in 2012.

Net Income (Loss) Attributable to Ultralife. Net income (loss) attributable to Ultralife and income (loss) attributable to Ultralife common shareholders per diluted share was $1,047 and $0.07, respectively, for the three months ended September 27, 2015, compared to ($323) and $(0.02), respectively, for the three months ended September 28, 2014. Average common shares outstanding used to compute diluted earnings per share decreased from 17,490,000 in the third quarter of 2014 to 15,727,000 in the third quarter of 2015 due primarily to the repurchase of stock under our Share Repurchase Plan.

Nine-month periods ended September 27, 2015 and September 28, 2014

Revenues. Consolidated revenues for the nine-month period ended September 27, 2015 amounted to $57,176, an increase of $10,630 or 22.8%, from the $46,546 reported for the nine-month period ended September 28, 2014.

Battery & Energy Products revenues increased $8,638, or 21.6%, from $40,000 for the nine-month period ended September 28, 2014 to $48,638 for the nine-month period ended September 27, 2015. Government and defense sales of this business increased 51.5% over the 2014 nine-month period and now comprise 45.1% of total segment sales versus 36.2% last year. The year-over-year growth was driven by higher shipments of batteries and chargers to a large international prime defense supplier and shipments of primary batteries to the U.S. Government’s Defense Logistics Agency. Commercial sales increased 1.5% over the 2014 period reflecting higher shipments of 9-Volt batteries to global smoke-detector OEM’s and rechargeable batteries into medical channels.

Communications Systems revenues increased $1,992, or 30.4%, from $6,546 during the nine-month period ended September 28, 2014 to $8,538 for the nine-month period ended September 27, 2015, reflecting increased demand from system integrators in support of U.S. Department of Defense programs and international projects.

Cost of Products Sold. Cost of products sold totaled $39,410 for the nine-month period ended September 27, 2015, an increase of $5,897, or 17.6%, from the $33,513 reported for the same nine-month period a year ago. Consolidated cost of products sold as a percentage of total revenue decreased from 72.0% for the nine-month period ended September 28, 2014 to 68.9% for the nine-month period ended September 27, 2015. Correspondingly, consolidated gross margin was 31.1% for the nine-month period ended September 27, 2015, compared with 28.0% for the nine-month period ended September 28, 2014, reflecting favorable product mix, higher production volume increasing the absorption of factory overhead and continued productivity improvements through the Company’s Lean process.

 21

For our Battery & Energy Products segment, the cost of products sold increased $5,027, from $29,511 during the nine-month period ended September 28, 2014 to $34,538 during the nine-month period ended September 27, 2015. Battery & Energy Products’ gross profit for the 2015 nine-month period was $14,100, or 29.0% of revenues, an increase of $3,611 from gross profit of $10,489, or 26.2% of revenues, for the 2014 nine-month period. Battery & Energy Products’ gross margin as a percentage of revenues increased for the nine-month period ended September 27, 2015 by 280 basis points, reflecting favorable mix, higher production volumes and ongoing productivity improvements through the Lean process.

For our Communications Systems segment, the cost of products sold increased by $870 or 21.7% from $4,002 during the nine-month period ended September 28, 2014 to $4,872 during the nine-month period ended September 27, 2015. Communications Systems’ gross profit for the first nine months of 2015 was $3,666, or 42.9% of revenues, an increase of $1,122 from gross profit of $2,544, or 38.9% of revenues, for the first nine months of 2014. The 400 basis points increase in gross margin as a percentage of revenue during 2015 is due to a greater mix of higher-margin new products and increased manufacturing throughput.

Operating Expenses. Total operating expenses for the nine-month period ended September 27, 2015 totaled $14,954, a decrease of $554 or 3.6% from the $15,508 recorded during the nine-month period ended September 28, 2014, resulting primarily from continued tight control over all discretionary spending.

Overall, operating expenses as a percentage of revenues were 26.2% for the nine-month period ended September 27, 2015 compared to 33.3% for the comparable 2014 period. Amortization expense associated with intangible assets related to our acquisitions was $180 for the first nine months of 2015 ($83 in selling, general and administrative expenses and $97 in research and development costs), compared with $232 for the first nine months of 2014 ($101 in selling, general, and administrative expenses and $131 in research and development costs). Research and development costs were $3,917 for the nine-month period ended September 27, 2015, a decrease of $93, or 2.3%, from $4,010 for the nine-months ended September 28, 2014, as we continued to focus our spending on the development of new products with the highest estimated return on investment. Selling, general, and administrative expenses decreased $461, or 4.0%, from $11,498 during the first nine months of 2014 to $11,037 during the first nine months of 2015, reflecting continued actions to reduce discretionary general and administrative expenses.

Other Income (Expense). Other (expense) totaled $(156) for the nine-month period ended September 27, 2015 compared to $(269) for the three-month period ended September 28, 2014. Interest and financing expense, net of interest income, increased $54, to $195 for the 2015 period from $141 for the comparable period in 2014, as a result of costs to insure certain non-U.S. accounts receivable consistent withour Credit Agreement with PNC Bank. Miscellaneous income (expense) amounted to $39 for the first nine months of 2015 compared with ($128) for the first nine months of 2014, primarily due to transactions impacted by changes in foreign currencies relative.

Income Taxes. We reflected a tax provision of $312 for the first three quarters of 2015 compared with a tax provision of $177 for the first three quarters of 2014. The increase of $135, or 76.3% was due to estimated U.S. alternative minimum taxes in 2015 and increased foreign tax liabilities. The effective consolidated tax rate for the nine-month periods ended September 27, 2015 and September 28, 2014 were:

 22

	Nine-month periods ended
	September 27,			June 29,
	2015			2014
Income (loss) income from continuing operations before
income taxes (a)	$	2,656		$	(2,744	)
Income tax provision (b)		312			177
Effective income tax rate (b/a)		11.7	%		(6.5	)%

See Note 8 in the Notes to Condensed Consolidated Financial Statements for additional information regarding our income taxes.

Discontinued Operations. Income (Loss) from discontinued operations, net of tax, totaled $0 for the first nine months of 2015, compared to ($61) for the comparable period in 2014. The loss for the 2014 period reflects the final settlement of the sale of our RedBlack business.

Net Income (Loss) Attributable to Ultralife. Net income (loss) attributable to Ultralife and income (loss) attributable to Ultralife common shareholders per diluted share was $2,367 and $0.14, respectively, for the nine months ended September 27, 2015, compared to $($2,969) and $(0.17), respectively, for the nine months ended September 28, 2014. Average common shares outstanding used to compute diluted earnings per share decreased from 17,510,000 in the 2014 period to 16,548,000 in the 2015 period, mainly due to the repurchase of stock under our Share Repurchase Plan, offset slightly by stock option exercises and the vesting of restricted stock units.

Adjusted EBITDA from Continuing Operations

In evaluating our business, we consider and use Adjusted EBITDA from continuing operations, a non-GAAP financial measure, as a supplemental measure of our operating performance. We define Adjusted EBITDA from continuing operations as net income (loss) attributable to Ultralife before net interest expense, provision (benefit) for income taxes, depreciation and amortization, plus/minus expenses/income that we do not consider reflective of our ongoing continuing operations. We use Adjusted EBITDA from continuing operations as a supplemental measure to review and assess our operating performance and to enhance comparability between periods. We also believe the use of Adjusted EBITDA from continuing operations facilitates investors’ use of operating performance comparisons from period to period and company to company by backing out potential differences caused by variations in such items as capital structures (affecting relative interest expense and stock-based compensation expense), the book amortization of intangible assets (affecting relative amortization expense), the age and book value of facilities and equipment (affecting relative depreciation expense) and other significant non-operating expenses or income. We also present Adjusted EBITDA from continuing operations because we believe it is frequently used by securities analysts, investors and other interested parties as a measure of financial performance. We reconcile Adjusted EBITDA from continuing operations to net income (loss) attributable to Ultralife, the most comparable financial measure under U.S. generally accepted accounting principles (“U.S. GAAP”).

 23

We use Adjusted EBITDA from continuing operations in our decision-making processes relating to the operation of our business together with U.S. GAAP financial measures such as income (loss) from operations. We believe that Adjusted EBITDA from continuing operations permits a comparative assessment of our operating performance, relative to our performance based on our U.S. GAAP results, while isolating the effects of depreciation and amortization, which may vary from period to period without any correlation to underlying operating performance, and of non-cash stock-based compensation, which is a non-cash expense that varies widely among companies. We believe that by limiting Adjusted EBITDA to continuing operations, we assist investors in gaining a better understanding of our business on a going forward basis. We provide information relating to our Adjusted EBITDA from continuing operations so that securities analysts, investors and other interested parties have the same data that we employ in assessing our overall operations. We believe that trends in our Adjusted EBITDA from continuing operations are a valuable indicator of our operating performance on a consolidated basis and of our ability to produce operating cash flows to fund working capital needs, to service debt obligations and to fund capital expenditures.

The term Adjusted EBITDA from continuing operations is not defined under U.S. GAAP, and is not a measure of operating income, operating performance or liquidity presented in accordance with U.S. GAAP. Our Adjusted EBITDA from continuing operations has limitations as an analytical tool, and when assessing our operating performance, Adjusted EBITDA from continuing operations should not be considered in isolation or as a substitute for net income (loss) attributable to Ultralife or other consolidated statement of operations data prepared in accordance with U.S. GAAP. Some of these limitations include, but are not limited to, the following:

· Adjusted EBITDA from continuing operations does not reflect (1) our cash expenditures or future requirements for capital expenditures or contractual commitments; (2) changes in, or cash requirements for, our working capital needs; (3) the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; (4) income taxes or the cash requirements for any tax payments; and (5) all of the costs associated with operating our business;

· although depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in the future, and Adjusted EBITDA from continuing operations does not reflect any cash requirements for such replacements;

· while stock-based compensation is a component of cost of products sold and operating expenses, the impact on our consolidated financial statements compared to other companies can vary significantly due to such factors as assumed life of the stock-based awards and assumed volatility of our common stock;

· although discontinued operations does not reflect our current business operations, discontinued operations includes the costs we incurred by exiting our Energy Services and certain of our UK businesses and divesting our RedBlack Communications business; and

· other companies may calculate Adjusted EBITDA from continuing operations differently than we do, limiting its usefulness as a comparative measure.

 24

We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA from continuing operations only supplementally. Adjusted EBITDA from continuing operations is calculated as follows for the periods presented:

	Three-month periods ended					Nine-month periods ended
	September 27,		September 28,			September 27,		September 28,
	2015		2014			2015		2014
Net income (loss) attributable
to Ultralife	$	1,047	$	(323	)	$	2,367	$	(2,969	)
Add (subtract):
Interest and financing expense, net		65		53			195		141
Income tax provision		130		60			312		177
Depreciation expense		617		709			1,795		2,174
Amortization of intangible assets		61		78			180		232
Stock-based compensation expense		135		238			439		761
Impairment of long-lived assets Loss (gain) from discontinued		—		—			36		—
operations		—		—			—		61
Adjusted EBITDA	$	2,055	$	815		$	5,324	$	577

Liquidity and Capital Resources

As of September 27, 2015, cash and cash equivalents totaled $14,585, a decrease of $3,126 from the beginning of the year. During the nine-month period ended September 27, 2015, we generated $7,428 of cash from our operating activities as compared to cash generated totaling $505 during the nine-month period ended September 28, 2014. Cash generated from operations in 2015 included our net income of $2,344 plus non-cash expenses (depreciation, amortization and stock-based compensation) totaling $2,502, and cash provided by a $2,621 decrease in inventories and $455 increase in accounts payable and other liabilities, offset partially by an increase in prepaid expenses and other assets of $630. Cash generated from operations in 2014 was positive despite our net loss of $2,982, as the loss was more than offset by non-cash expenses totaling $3,180. Cash generated from operations in 2014 resulted primarily from a $3,755 decrease in accounts receivable, offset partially by our loss of $2,982, a decrease in accounts payable and other liabilities of $1,017 and an increase in inventories which totaled $2,460.

Inventory turnover for the first nine months of 2015 was an annualized rate of approximately 2.1 turns per year, a slight improvement over the 2.0 figure from the first nine months of 2014.

We used $1,298 in cash for investing activities during the nine month period ended September 27, 2015 compared with $968 in cash used for investing activities in the same period in 2014. In both periods, this spending was principally for the purchase of property, equipment and improvements.

As of September 27, 2015, we had made commitments to purchase approximately $358 of production machinery and equipment, which we expect to fund through operating cash flows or debt borrowings.

 25

On April 28, 2014, the Company’s Board of Directors approved a share repurchase program (the “Share Repurchase Program”) which became effective on May 1, 2014, under which the Company was initially authorized to repurchase up to 1.8 million shares of its outstanding common stock over a period not to exceed twelve months. On April 28, 2015, the Board of Directors authorized an extension of the Share Repurchase Program for an additional twelve month period beginning May 1, 2015 and ending April 30, 2016, subject, for the entire period as extended, to the 1.8 million share aggregate limit established in the initial authorization.  On June 2, 2015, the Board of Directors approved an expansion and extension of the Share Repurchase Program, authorizing the repurchase of up to an additional 1.6 million shares through June 2, 2016.

Share repurchases under this program are made in accordance with SEC Rule 10b-18 using a variety of methods, which may include open market purchases, privately negotiated transactions and block trades, or any combination of such methods, in compliance with applicable insider trading and other securities laws and regulations. With the exception of repurchases made during stock trading black-out periods under a 10b5-1 Plan, the timing, manner, price and amount of any repurchase are determined at the Company’s discretion. The Share Repurchase Program may be suspended, terminated or modified by the Company at any time and for any reason.  The Share Repurchase Program does not obligate the Company to repurchase any specific number of shares.

During the three month period ended September 27, 2015, the Company repurchased 748,582 shares under our Share Repurchase Program for a total cost (excluding fees and commissions) of $3,357. During the nine month period ended September 27, 2015, the Company repurchased 2,225,437 shares under this program for a total cost (excluding fees and commissions) of $9,162. From the inception of the Share Repurchase Program on May 1, 2014 through October 28, 2015, the Company has repurchased 2,442,191 shares for an aggregate cost (excluding fees and commissions) of $9,877. The total remaining balance of shares authorized for repurchase under the Share Repurchase Program is 957,809 shares as of October 28, 2015.

Debt Commitments

We have financing through our Credit Facility with PNC Bank, which provides a $20 million secured asset-based revolving credit facility that includes a $1 million letter of credit sub-facility. As of September 27, 2015, we had approximately $9,666 of borrowing capacity under our $20 million Credit Facility with PNC Bank, in addition to our cash on hand of $14,585, and we had no outstanding borrowings or outstanding letters of credit under the Credit Facility at either September 27, 2015 or September 28, 2014.

Our available borrowing limit under the Credit Facility is based on a borrowing base formula equal to a percentage of accounts receivable, inventory and eligible foreign in-transit inventory. Interest is payable quarterly and accrues on outstanding indebtedness under the Credit Agreement at either a LIBOR-based rate or an alternate base rate, as defined in the Credit Agreement. We pay a quarterly fee on the Credit Facility’s unused availability at 0.375% per annum.

Other Matters

With respect to our battery products, we typically offer warranties against any defects due to product malfunction or workmanship for a period up to one year from the date of purchase. With respect to our communications accessory products, we typically offer a three-year warranty. We provide for a reserve for these potential warranty expenses, which is based on an analysis of historical warranty issues. There is no assurance that future warranty claims will be consistent with past history, and in the event we experience a significant increase in warranty claims, there is no assurance that our reserves would be sufficient. This could have a material adverse effect on our business, financial condition and results of operations.

 26

Critical Accounting Policies

Management exercises judgment in making important decisions pertaining to choosing and applying accounting policies and methodologies in many areas. Not only are these decisions necessary to comply with U.S. GAAP, but they also reflect management’s view of the most appropriate manner in which to record and report our overall financial performance. All accounting policies are important, and all policies described in Note 1 (“Summary of Operations and Significant Accounting Policies”) to our Consolidated Financial Statements in our 2014 Annual Report on Form 10-K should be reviewed for a greater understanding of how our financial performance is recorded and reported.

During the first nine months of 2015, there were no significant changes in the manner in which our significant accounting policies were applied or in which related assumptions and estimates were developed.

ITEM 4. Controls and Procedures

Evaluation Of Disclosure Controls And Procedures

Our President and Chief Executive Officer (Principal Executive Officer) and our Chief Financial Officer and Treasurer (Principal Financial Officer) have evaluated our disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e)) as of the end of the period covered by this quarterly report. Based on this evaluation, our President and Chief Executive Officer and Chief Financial Officer and Treasurer concluded that our disclosure controls and procedures were effective as of such date.

Changes In Internal Control Over Financial Reporting

There has been no change in our internal control over financial reporting (as defined in Securities Exchange Act Rule 13a-15(f)) that occurred during the fiscal quarter covered by this quarterly report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

Dreamliner Litigation

In July 2013, an unoccupied Boeing 787 Dreamliner aircraft operated by Ethiopian Airlines was damaged by a fire while parked at London Heathrow Airport. We participated in and provided technical assistance in support of an investigation of this incident conducted by UK and US regulatory authorities as well as by the manufacturer of the aircraft, as we are one of many downstream suppliers to that manufacturer.  A final report was issued by the Air Accidents Investigative Branch - - UK Civil Aviation regulatory authority, with findings indicating that the fire was caused by circumstances related to the plane’s emergency locator transmitter (“ELT”) manufactured and installed by another company. 

 27

On May 4, 2015, we were notified of a lawsuit in which we were named, along with other suppliers to the aircraft manufacturer, concerning that 2013 fire. The suit was filed by Ethiopian Airlines Enterprise in the Commercial Court, Queen’s Bench Division of the High Court of Justice, London. The suit seeks as damages USD 42 million plus other unspecified amounts, including those for loss of use and diminution in value of the aircraft. We maintain liability and products liability insurance through reputable providers, and in accordance with our corporate practices, immediately advised and referred this matter to our insurers. We are working with those insurers and their counsel to respond to and actively defend against this action.

A component of the ELT is a battery pack which incorporates Ultralife’s industry-standard lithium manganese dioxide non-rechargeable D-cell. Ultralife has had this cell in production since 2001, with millions of units produced and this cell is widely-used for global defense and commercial applications. This battery product has gone through rigorous safety and qualification testing, including United Nations Transport of Dangerous Goods, Manual of Tests and Criteria, and is authorized for use in aerospace applications under Technical Standard Order C142.

At this time, we believe that there is not a reasonable possibility that this incident will result in a material financial exposure to the Company.

Arista Power Litigation

In September 2011, we initiated an action against Arista Power, Inc. (“Arista”) and our former employee, David Modeen (“Modeen”), in the State of New York Supreme Court, County of Wayne, in which we allege that Arista recruited all but one of the members of its executive team from us, subsequently changed and redirected its business to compete directly with us by using our confidential information, and during the summer of 2011, recruited Modeen to become an Arista employee. As more fully disclosed in our Annual Report on Form 10-K, we allege that both Arista and Modeen breached agreements with us, that Arista’s employment of Modeen will inevitably lead to the disclosure and use of our trade secrets by Arista.  We seek damages as determined at trial and preliminary and permanent injunctive relief.  The defendants answered the allegations set forth in the Complaint and asserted claims against us, which have since been dropped.  

We initiated the September 2011 Complaint against Arista Power to protect our shareholders, customersand employees from the unauthorized use and theft of our investments in intellectual property, trade secrets and confidential information by Arista and its employees.  Protecting our intellectual property and know-how, developed and obtained at great cost to us to form our competitive position in the marketplace and create value for our shareholders and stakeholders, is a fundamental responsibility of all our employees.

Discovery in this action is ongoing, and we plan to continue to pursue our complaint against Arista.  It is not possible to predict the outcome of this action, whether we will be granted the injunctive relief we seek, nor the monetary amount, if any, which we may be awarded should we prevail.

 28

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

2(c) Purchases of Equity Securities by the Issuer and Affiliated Purchasers

The following table sets forth information regarding second quarter 2015 purchases of common stock under the Company’s stock repurchase program. Under the repurchase program, the Board of Directors initially authorized the repurchase of up to 1.8 million shares of the Company’s Common Stock through April 30, 2015. The Board of Directors has since extended the program through June 2, 2016 and expanded the maximum number of shares authorized to be repurchased from 1.8 million shares to 3.4 million shares.

Since the commencement of this repurchase plan through September 27, 2015, the Company has repurchased 2,442,191 common shares under this plan for an aggregate dollar amount of $9,951.

	Total Number of Shares Purchased		Average Price Paid Per Share(1)		Total Number of Shares Purchased as Part of Publicly Announced Program		Maximum Number of Shares That May Yet Be Purchased Under the Program
June 29 – July 26		201,971	$	4.05		201,971		1,504,420
July 27 – August 23		46,611		4.05		46,611		1,457,809
August 24 – September 27		500,000		4.70		500,000		957,809
Total		1,398,454	$	4.48		1,398,454		957,809

⁽¹⁾Average Price Paid Per Share excludes fees and commissions related to such repurchases. Including these costs, the average price paid per share for all purchases under the Share Repurchase Program is $4.51.

ITEM 6. EXHIBITS

Exhibit Index	Description of Document	Incorporated By Reference from:
31.1	Rule 13a-14(a) / 15d-14(a) CEO Certifications	Filed herewith
31.2	Rule 13a-14(a) / 15d-14(a) CFO Certifications	Filed herewith
32	Section 1350 Certifications	Filed herewith
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Calculation Linkbase Document
101.LAB	XBRL Taxonomy Label Linkbase Document
101.PRE	XBRL Taxonomy Presentation Linkbase Document
101.DEF	XBRL Taxonomy Definition Document

 29

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ULTRALIFE CORPORATION
	(Registrant)
Date: October 29, 2015	By:   /s/  Michael D. Popielec
	Michael D. Popielec
	President and Chief Executive Officer
	(Principal Executive Officer)
Date: October 29, 2015	By:   /s/  Philip A. Fain
	Philip A. Fain
	Chief Financial Officer and Treasurer
	(Principal Financial Officer and
	Principal Accounting Officer)

Index to Exhibits

31.1 Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2 Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS XBRL Instance Document

101.SCH XBRL Taxonomy Extension Schema Document

101.CAL XBRL Taxonomy Calculation Linkbase Document

101.LAB XBRL Taxonomy Label Linkbase Document

101.PRE XBRL Taxonomy Presentation Linkbase Document

	101.DEF	XBRL Taxonomy Definition Document
30